Discovery of NovelN-Substituted Oxindoles as Selective M1and M4Muscarinic Acetylcholine Receptors Partial Agonists
Citations Over TimeTop 21% of 2013 papers
Abstract
Activation of the M1 and M4 muscarinic acetylcholine receptors is thought to play an important role in improving the symptoms of schizophrenia. However, discovery of selective agonists for these receptors has been a challenge, considering the high sequence homology and conservation of the orthosteric acetylcholine binding site among muscarinic acetylcholine receptor subtypes. We report in this study the discovery of novel N-substituted oxindoles as potent muscarinic acetylcholine receptor partial agonists selective for M1 and M4 over M2, M3, and M5. Among these oxindoles, compound 1 showed high selectivity for the M1 and M4 receptors with remarkable penetration into the central nervous system. Compound 1 reversed methamphetamine- and apomorphine-induced psychosis-like behaviors with low potency to extrapyramidical and peripheral side effects.
Related Papers
- → Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice(1999)350 cited
- → Muscarinic receptor subtypes mediating central and peripheral antinociception studied with muscarinic receptor knockout mice(2003)99 cited
- → Epithelial muscarinic M1 receptors contribute to carbachol-induced ion secretion in mouse colon(2006)40 cited
- → CHANGES IN MUSCARINIC RECEPTORS IN THE TOAD UROTHELIAL CELL LINE TBM‐54 FOLLOWING ACROLEIN TREATMENT(2007)5 cited
- → Ontogeny of muscarinic acetylcholine receptor expression and muscarinic receptor mediated immediate early gene induction in the rat CNS(1993)